Side Glow Fiber is different from solid core side glow fiber. It is a new and green lighting product, of which the diameter ranges from 0.75mm to 3.0mm.
DSPO manufacture a range of fibre optic side glow, which are used widely on all sorts of decoration engineering , such as building , nightclub , disco , hotel , market , plaza and museum , and honored as an honored as an ideal material to replaced current means of decorative illumination.
We make customized different size of side glow fibre optic , you are welcome to let us know your requirements and application . Fibre Optic Side Glow,Side Glow Fibre Optic,Side Glow Optical Fiber,Side Emitting Fibre Optic Jiangxi Daishing POF Co.,Ltd , https://www.jxopticfibrelight.com
Anntech Technology Co., Ltd. Announcement on Transferring Part of Equity Interest in Antai Biomedical Materials Co., Ltd.
Interpretation:
Unless otherwise stated, the following abbreviations have the following meanings in this announcement:
Antai Technology, Company, the company: Antai Technology Co., Ltd.
Antai Bio: Beijing Antai Biomaterials Co., Ltd.
Jingke Gaochuang: Jingke Gaochuang (Beijing) New Technology Co., Ltd.
First, the transaction overview
The company intends to transfer the entire shareholding (3.35%) of Antai Biotech held by Jingke Gaochuang to no more than RMB 1.1 million. After the transaction is completed, the company's shareholding ratio of Antai Biotech will become 96.65%.
The company held the 19th meeting of the 5th Board of Directors on August 13, 2013. After careful deliberation, the meeting passed the “Proposal on the Transfer of 3.35% Equity of Antai Biomedical Materials Co., Ltd. of Antai Technology Co., Ltd.†The proposal does not need to be submitted to the shareholders meeting for consideration.
The transaction does not constitute a connected transaction and does not meet the major asset restructuring standards stipulated by the China Securities Regulatory Commission's Measures for the Administration of Major Asset Restructuring of Listed Companies, and does not need to be reported to the China Securities Regulatory Commission for approval.
Second, the basic situation of the other party to the transaction
Jingke Gaochuang (Beijing) New Technology Co., Ltd.
Company type: limited liability company
Place of registration: No. -8, No. 12, Baifuquan Road, Changping District, Beijing
Main office: No. -8, No. 12, Baifuquan Road, Changping District, Beijing
Legal representative: Yan Wei
Registered capital: 44.8654 million yuan
Business license registration number
Founded in 1992, Jingke Gaochuang is a wholly-owned limited liability company of Beijing High Technology Entrepreneurship Service Center. The business scope mainly includes: technology development, technical consultation, technology promotion, and technical services.
Third, the basic situation of the subject of this transaction
1. Beijing Antai Biomaterials Co., Ltd.
Company type: limited liability company
Place of registration: No. 12, Yongcheng North Road, Yongfeng Industrial Base, Zhongguancun, Haidian District, Beijing
Main office: No. 12, Yongcheng North Road, Yongfeng Industrial Base, Zhongguancun, Haidian District, Beijing
Legal representative: Zhou Shaoxiong
Registered capital: 30 million yuan
Business license registration number
Main business: dental materials and interventional materials and instruments.
2. The equity status of Antai Bio
As of now, the equity structure of Aetna Bio is as follows:
Antai Technology Co., Ltd. holds 93.3% of the shares;
China Steel Research Technology Group Co., Ltd., holding 3.35%;
Jingke Gaochuang (Beijing) New Technology Development Co., Ltd. holds 3.35%.
3. The main financial data of Antai Bio
Unit: 10,000 yuan
Project 2010 2011 2012
Total assets 3543.47 4098.77 3440.87
Net assets 3252.575 3376.29 3223.22
Operating income 2556.93 2948.37 3179.74
Total profit -58.55 202.59 -52.35
Net profit -60.27 121.54 -73.08
Fourth, the main content of this transaction
1. The subject and price of the transaction
According to the evaluation report of Zhongjing Minxin (Beijing) Assets Appraisal Co., Ltd. (Jingxin Pingbao (2013) No. 127, the evaluation base date is December 31, 2012), the estimated value of Antai Bio-Enterprises is RMB 32,326,900. The value of 3.35% equity held by Jingke Gaochuang is 1.0579 million yuan, and the proposed transfer price is not more than 1.1 million yuan.
2. Source of funds: The company's own funds.
V. The purpose of this transaction and its impact on the company
Antai Bio-industry is an industry encouraged and prioritized by the state. The implementation of this project will help optimize the ownership structure and further promote business development.
The acquisition of equity will not have a significant impact on the company's profits.
Sixth, the file directory for reference
1. Resolutions of the 19th meeting of the fifth board of directors of the company;
2. Antai Technology Co., Ltd. Equity Acquisition Project Beijing Antai Biomedical Materials Co., Ltd. Shareholders' equity value assets assessment report (Jingxin Evaluation Report (2013) No. 127).
Antai Technology Co., Ltd.
August 13, 2013
Used with various light sources such as LED light source, Metal Halide light source, Halogen light source etc., fiber optic lighting has following advantages:
1. Color changing, which is virtually unbreakable and energy efficient;
2. Suitable for interior and exterior applications. It is UV protected, which has an algaecide and fungicide treated exterior jacket for maximum durability against the elements.
3. Side Glow fiber optic cable is strong enough for amusement park rides, extreme cold weather as well as underwater applications. With no heat or electricity in the cable, it is safer compared with typical lighting design restrictions.
Abstract Stock code: 000969 Securities abbreviation: Antai Technology Announcement No.: 2013-027 Antai Technology Co., Ltd. Announcement on the Transfer of Partial Equity of Antai Biomedical Materials Co., Ltd. The Company and its Director
Stock code: 000969 Stock abbreviation: Antai Technology Announcement No.: 2013-027
The Company and its directors guarantee the truthfulness, accuracy and completeness of the contents of the announcement, and there are no false records, misleading statements or major omissions.